Natera, Inc. Logo

Natera, Inc. (45E)

FSX

Currency in EUR
353.80
-1.30 (-0.37%)

Real-time Data

06:00 AM

Day's Range

352.20
355.60

52 wk Range

86.00
386.00

Overview - 45E - Natera, Inc.

Key Statistics

Valuation

Enterprise Value

44.98B

P/E (Trailing)

‪-237.96‬

P/E (Forward)

‪-19.23‬

PEG Ratio

‪6.52‬

Price / Sales (TTM)

‪19.25‬

Price / Book

‪32.73‬

EV / EBITDA

‪-228.51‬

Profitability

Gross Margin

‪64.45%‬

Profit Margin

‪-7.10%‬

Operating Margin

‪-10.29%‬

Return on Assets

‪-8.07%‬

Return on Equity

‪-12.54%‬

Ownership

Shares Outstanding

143.61M

Float

140.09M

Held by Insiders

‪2.81%‬

Held by Institutions

‪96.73%‬

Price stats

Beta

‪1.53‬

50-Day Avg

‪270.96‬

200-Day Avg

‪208.36‬

Dividends

Payout Ratio

‪0.00%‬

News Teaser - 45E - Natera, Inc.

News & Analysis

View all news

Market Cap - 45E - Natera, Inc.

Peers - 45E - Natera, Inc.

Peer Comparison

Compared with companies in Diagnostics & Research listed on FSX.

Profile Summary - 45E - Natera, Inc.

About

Natera, Inc. is a molecular diagnostics company that develops and commercializes cell-free DNA and genetic testing services for clinical use. The company focuses on oncology, women’s health, and organ health, using proprietary molecular assays and bioinformatics to help detect and monitor genetic conditions and…

SectorHealthcare
IndustryDiagnostics & Research
Employees4.42K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.